Literature DB >> 8752153

Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density.

A N Koura1, W Liu, Y Kitadai, R K Singh, R Radinsky, L M Ellis.   

Abstract

To determine the effect of cell density on vascular endothelial growth factor (VEGF) expression and the mechanism of this effect, four human colon cancer cell lines were grown as sparse or confluent monolayers or as spheroids. VEGF mRNA increased > 2-fold in cells grown as confluent monolayers or spheroids compared with cells grown as sparse monolayers. Semiquantitative reverse transcription-PCR demonstrated a 2-fold increase in the larger VEGF mRNA isoform (189 bp) in confluent cells. Sparse cells grown in conditioned medium from confluent cells demonstrated a > 2-fold increase in VEGF mRNA. These data suggest that VEGF expression may be regulated by an unidentified soluble factor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8752153

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

2.  Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells.

Authors:  S Yano; H Shinohara; R S Herbst; H Kuniyasu; C D Bucana; L M Ellis; I J Fidler
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  High cell density induces vascular endothelial growth factor expression via protein tyrosine phosphorylation.

Authors:  D Mukhopadhyay; L Tsiokas; V P Sukhatme
Journal:  Gene Expr       Date:  1998

Review 4.  The hemostatic system and angiogenesis in malignancy.

Authors:  M Z Wojtukiewicz; E Sierko; P Klement; J Rak
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

5.  Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosa.

Authors:  Antti-J Kivela; Seppo Parkkila; Juha Saarnio; Tuomo-J Karttunen; Jyrki Kivela; Anna-Kaisa Parkkila; Maria Bartosova; Vojtech Mucha; Michal Novak; Abdul Waheed; William-S Sly; Hannu Rajaniemi; Silvia Pastorekova; Jaromir Pastorek
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

6.  Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.

Authors:  K M Lonergan; O Iliopoulos; M Ohh; T Kamura; R C Conaway; J W Conaway; W G Kaelin
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

7.  Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells.

Authors:  Fan Fan; Michael J Gray; Nikolaos A Dallas; Anthony D Yang; George Van Buren; E Ramsay Camp; Lee M Ellis
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

8.  Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis.

Authors:  Ratchada Cressey; Onusa Wattananupong; Nirush Lertprasertsuke; Usanee Vinitketkumnuen
Journal:  BMC Cancer       Date:  2005-10-04       Impact factor: 4.430

9.  Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer.

Authors:  T Tokunaga; Y Oshika; Y Abe; Y Ozeki; S Sadahiro; H Kijima; T Tsuchida; H Yamazaki; Y Ueyama; N Tamaoki; M Nakamura
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

10.  Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1beta.

Authors:  Y Akagi; W Liu; K Xie; B Zebrowski; R M Shaheen; L M Ellis
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.